Construction of chimeric Arctic-like rabies virus glycoproteins improves pseudotyped virus titre to permit use in serological studies

Bentley, E., Ali, R., Horton, D., Banyard, A.C. and Wright, E. 2014. Construction of chimeric Arctic-like rabies virus glycoproteins improves pseudotyped virus titre to permit use in serological studies. IMED 2014. Vienna, Austria Oct 2014

TitleConstruction of chimeric Arctic-like rabies virus glycoproteins improves pseudotyped virus titre to permit use in serological studies
AuthorsBentley, E., Ali, R., Horton, D., Banyard, A.C. and Wright, E.
TypeConference poster
Abstract

Background: The Arctic-like rabies viruses (AL RABV) constitute a lineage of RABV circulating in the Middle East and Asia with distinct antigenic and genetic characteristics. As with all lyssaviruses, AL RABV cause an invariably fatal disease of mammals with zoonotic implications. A RABV glycoprotein (G) lentiviral pseudotyped virus (PV) has shown to be a highly sensitive and specific surrogate to live virus in neutralisation assays. However, using wildtype AL RABV G failed to generate infectious PV.

Objective: To generate AL RABV PV with chimeric G and compare titres achieved with PVs bearing wildtype G. Undertake serology studies to determine the efficacy of current vaccines and antivirals against this RABV subset.

Methods: Chimeras were constructed by splicing the ecto- and transmembrane domains of four AL RABV G strains with the cytoplasmic domains of vesicular stomatitis virus (VSV) G or RABV challenge virus standard-11 (CVS-11) G. PV generation followed a three plasmid transfection protocol and neutralisation assays (IC100) were undertaken using a panel of sera.

Results: Comparison of PV expressing wildtype or chimeric G revealed chimeric AL RABV with a VSV G cytoplasmic domain significantly increased PV titres (22-2200 fold). When comparing wildtype and VSV G based chimeric G PVs the latter showed neutralisation occurred within a single doubling serum dilution. AL RABV chimeric PV were neutralised by a range of the serum samples tested.

Conclusion: Infectious PV titre is effectively improved for AL RABV through the generation of chimeric G with a VSV G cytoplasmic domain. Comparison of chimeric and wildtype G PV shows switching the cytoplasmic domain does not affect the neutralisation profile. AL RABV are neutralised by responses to existing vaccines and therapeutics. On-going serological studies will fully evaluate the efficacy of current vaccines and antivirals against these viruses.

Year2014
ConferenceIMED 2014

Related outputs

The study of highly pathogenic emerging zoonotic virus envelope proteins through pseudotyped virus generation
Bentley, E. 2017. The study of highly pathogenic emerging zoonotic virus envelope proteins through pseudotyped virus generation. PhD thesis University of Westminster Biomedical Sciences

Ebolavirus pseudotypes as antigen surrogates for serological studies
Bentley, E., Mattiuzzo, G., Wash, R., Binter, S., Friedrich, M., Goulding, D., Kellam, P., Page, M. and Wright, E. 2016. Ebolavirus pseudotypes as antigen surrogates for serological studies. International Journal of Infectious Diseases. 53 (Supplement), p. 123.

Exploiting viral pseudotypes for emerging virus research
Grehan, K., Bentley, E., Mather, S., Kinsley, R., Scott, S.D., Wright, E. and Temperton, N.J. 2016. Exploiting viral pseudotypes for emerging virus research. International Journal of Infectious Diseases. 53 (Supplement), p. 8.

Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model
Miller, J.L., Spiro, S.G., Dowall, S.D., Taylor, I., Rule, A., Alonzi, D.S., Sayce, A.C., Wright, E., Bentley, E.M., Thom, R., Hall, G., Dwek, R.A., Hewson, R. and Zitzmann, N. 2016. Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model. PLoS ONE.

Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis
Wright, E., Benedictis Paola, D., Minola, A., Rota Nodari, E., Aiello, R., Zecchin, B., Salomoni, A., Foglierini, M., Agatic, G., Vanzetta, F., Lavenir, R., Lepelletier, A., Bentley, E., Weiss, R.A., Cattoli, G., Capua, I., Sallusto, F., Lanzavecchia, A., Bourhy, H., Corti, D. and De Benedictis, P. 2016. Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis. EMBO Molecular Medicine. 8 (4), pp. 407-421.

Construction of chimeric Arctic-like rabies virus glycoproteins rescues pseudovirus titre to permit use in serological studies
Bentley, E., Ali, R., Horton, D., Banyard, A.C. and Wright, E. 2014. Construction of chimeric Arctic-like rabies virus glycoproteins rescues pseudovirus titre to permit use in serological studies. Society for General Microbiology Spring Conference. Liverpool, UK Apr 2014

The construction of chimeric rabies virus glycoproteins rescues Arctic-like rabies pseudovirus production
Bentley, E., Ali, R., Horton, D.L., Banyard, A.C. and Wright, E. 2013. The construction of chimeric rabies virus glycoproteins rescues Arctic-like rabies pseudovirus production. Pseudotype viruses: applications and troubleshooting. London, UK October 2013

Permalink - https://westminsterresearch.westminster.ac.uk/item/94z37/construction-of-chimeric-arctic-like-rabies-virus-glycoproteins-improves-pseudotyped-virus-titre-to-permit-use-in-serological-studies


Share this
Tweet
Email